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The topic of combined exposures to
endocrine disruptors (EDs) has long been
regarded as important, not least because of the
continuing discovery of ever new chemicals
with endocrine-disrupting potential and the
realization that exposure is to a multitude of
chemicals simultaneously, not to single agents.
Yet, Yang’s observation (Yang 1994) that
> 95% of the resources in toxicologic research
are devoted to the study of single chemicals,
with an almost complete neglect of mixture
studies, also applies to ED research. A con-
tributing factor to this imbalance is no doubt
the inaccessibility of theoretical concepts in
mixture toxicology and the resulting uncer-
tainty as to how to proceed experimentally.
To complicate matters further, the early work
on mixtures of EDs was motivated by a sys-
tematic search for synergisms. In 1996, a
report claiming spectacular synergisms
between binary mixtures of estrogenic pesti-
cides was published (Arnold et al. 1996), but
had to be withdrawn because the experimental
results could not be reproduced by other labo-
ratories (Ashby et al. 1997; Ramamoorthy
et al. 1997). This episode has led many to
question the overall importance of combina-
tion effects of EDs. In addition, mixture stud-
ies are perceived to be challenging, both
conceptually and experimentally—concerns
that have led the U.S. Environmental
Protection Agency (EPA) Science Advisory
Board (SAB) and Science Advisory Panel to
recommend a delay in the screening and test-
ing of mixtures for hormonal potential until
the feasibility of such approaches could be
assessed with the benefit of data on individual
chemicals (SAB 1999).
In spite of these difficulties, perceived or
real, many articles on combination effects of
EDs have been published in the last 10 years,
and it is timely to assess what progress has
been made. A review of the evidence is also
motivated by the fact that certain legislative
and regulatory frameworks in some countries
mandate consideration of groups of chemicals
that act via the same mechanism, rather than
evaluating the potential risks on an individual
basis. Over 20 years ago, this risk assessment
approach found entry into the regulation of
polyhalogenated dioxins and furans, where the
application of the toxic equivalency factor/
toxic equivalences (TEF/TEQ) concept is
now common practice (van den Berg et al.
1998). Is there sufficient evidence about com-
bination effects of EDs to call for similar
cumulative risk assessment approaches? Where
are knowledge gaps, and what are conceptual
difficulties? A review of the earlier work on
ED mixtures, leading up to 1997, has been
published (Kortenkamp and Altenburger
1998). In the present article, I concentrate on
studies that appeared after 1997 in the peer-
reviewed literature.
In studying ED mixtures, many researchers
have followed what has been called a “whole
mixture approach” (U.S. EPA 1986), in which
a combination of many chemicals is investi-
gated as if it were a single agent, but the indi-
vidual effects of all the components are not
assessed. This type of experiment is useful for
studying complex mixtures, or on a case-by-
case basis, but leads to difficulties in extrapolat-
ing from one mixture to the other because
small variations in composition may lead to
significant changes in its toxic effects.
Furthermore, whole mixture approaches do
not answer whether chemicals act in an addi-
tive, antagonistic, or synergistic fashion.
However, one of the major difficulties in
assessing EDs is uncertainty about their poten-
tial to act together in an additive or synergistic
manner (Daston et al. 2003). To address these
concerns, I focus on studies that have assessed
ED mixtures in terms of additivity, antago-
nism, or synergy. Typically, such studies
attempt to predict additive combination effects
on the basis of information about the effects of
all components in the mixture. Not all types of
mixtures lend themselves to this approach; for
example, one chemical, which by itself does
not induce the effect of interest, can modify
the responses provoked by a second agent. In
these cases, the resulting combination effect is
difficult to predict from knowledge about the
effect profile of the individual components.
Often, however, all mixture components
themselves induce the effect of interest; in
these cases, it may be possible to anticipate the
resulting joint effect by making assumptions
about expected additivity.
The use of the term “additivity” in mixture
toxicology still causes much confusion, partly
because it is not always synonymous with addi-
tivity in the mathematical sense. In toxicology,
mixture “additivity” describes the case in
which chemicals “act together” to produce
effects without enhancing or diminishing each
other’s action. There are various models for
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dealing with this kind of additivity, and the
choice of a “correct” one is of great impor-
tance, because it is in relation to these additiv-
ity expectations that combination effects are
evaluated in terms of synergisms (effects greater
than additive) or antagonisms (effects falling
short of additivity). Choosing an inappropriate
additivity expectation as a point of reference
may result in combination effects being erro-
neously determined as additive, synergistic, or
antagonistic. Thus, before reviewing endocrine
mixtures, a brief introduction into concepts for
calculating mixture additivity is in order. An
in-depth discussion of this topic is beyond the
scope of this review, but additional informa-
tion has been published by Berenbaum (1981,
1989) and Greco et al. (1995).
What Is Additivity?
It is often said that the effects of a combina-
tion of chemicals may be smaller or larger
than the sum of the individual effects of all
components. Without further justification,
this is frequently taken to mean that the
anticipated combination effect is accessible by
calculating the simple arithmetic sum of the
individual effects of all chemicals. The fallacy
of this expectation has been discussed else-
where (Berenbaum 1981; Kortenkamp and
Altenburger 1998), but it becomes obvious
when we consider, for example, 10 agents,
each of which provokes 15% of a certain
response. The anticipation that the resulting
joint effect should be 10 × 15% = 150%
turns out to be biologically impossible if the
maximally inducible effect can only be 100%.
Thus, approaches are required that provide
more reliable calculations of mixture effects,
such that a reference point for the assessment
of combination effects in terms of synergisms,
additivity, and antagonism can be defined. For
this purpose, two concepts are available: dose
addition (often referred to as concentration
addition) and independent action. These con-
cepts are used depending on the presumed
modes of action of the mixture components.
Dose addition is applied to mixtures of
chemicals that exert their effects through simi-
lar modes of action. Examples include
organophosphorus pesticides and polychlori-
nated dioxins (PCDDs) and polychlorinated
furans (PCDFs). Because these chemicals
interact with well-defined molecular targets, it
is thought that one chemical can be replaced
totally or in part by an equal fraction of an
equieffective concentration of another without
diminishing the overall combined effect
(Loewe and Muischnek 1926). A widely used
application of dose addition is the TEF/TEQ
concept for the assessment of mixtures of
PCDDs and PCDFs (Safe 1998; van den Berg
et al. 1998). A great deal of the work on ED
mixtures has utilized dose addition or concen-
tration addition as the concept for calculating
additivity expectations. Considering that the
majority of mixture studies have been based
on end points relatively close to the steps fol-
lowing hormone-receptor binding and activa-
tion, the choice of dose addition appears to be
well-founded.
Independent action (also called “response
addition”) is used for combinations of agents
with diverse modes of action. By activating
differing effector chains, every component of
a mixture of dissimilarly acting chemicals is
thought to provoke effects independent of all
other agents that might also be present. The
resulting combined effect can be calculated
from the effects caused by the individual mix-
ture components by adopting the statistical
concept of independent events (Bliss 1939).
Independent action (often confusingly also
referred to as “response addition” or “effect
multiplication”) has been used rarely for mix-
tures of EDs.
Both dose (or concentration) addition and
independent action are able to account for sat-
uration effects at higher effect doses and will
not produce paradoxical predictions of supra-
maximal combination effects such as in the
example described above with 10 compounds,
each inducing a 15% effect. 
In this article, I will discuss work with the
three most frequently studied hormone recep-
tors: the estrogen receptor, the androgen
receptor (AR), and the thyroid receptor.
There is a rich literature concerning the aryl
hydrocarbon receptor (AhR), which has been
reviewed elsewhere (van den Berg et al. 1998)
and will consequently not be dealt with here,
but interactions between AhR agonists and
other EDs will be considered.
Mixtures of Estrogenic
Chemicals
Estrogenic chemicals have been the focus of
most of the work on EDs, and it is not surpris-
ing that this group of substances has been the
topic of the majority of ED mixture studies.
Although the earlier efforts mainly employed
binary mixtures (reviewed by Kortenkamp and
Altenburger 1998), work carried out since
1998 has made significant contributions to the
analysis of multicomponent mixtures contain-
ing 3, often 5, and up to 12 estrogenic chemi-
cals. “Estrogenicity” can be defined in various
ways. At the functional, physiologic level, the
term denotes the ability of a chemical to evoke
responses similar to those of 17β-estradiol (E2),
such as cornification of the vaginal epithelium
and uterine cell proliferation. Of toxicologic
concern is the role of estrogens in breast and
ovarian cancer, and E2 and synthetic estro-
gens are recognized human carcinogens.
Advances in our understanding of the mode
of action of estrogens have led to further defi-
nitions that refer to specific steps at various
molecular levels. These definitions provide a
way to structure the evidence on estrogen
mixtures; thus, ”estrogenicity” can mean
affinity to the estrogen receptor (ER-α or
ER-β) (although this does not distinguish
agonists from antagonists), the ability to acti-
vate expression of estrogen-dependent genes,
or stimulation of cell proliferation of ER-
competent cells. At present, no post-1998
multicomponent study with ER binding as
the end point is available.
ER activation. Payne et al. (2000) studied
combinations of two, three, and four estro-
genic chemicals in the yeast estrogen screen, an
ER-α–based gene reporter system. Individual
dose–response curves for o,p´-DDT, genistein,
4-nonylphenol, and 4-n-octylphenol were
recorded, and this information was used to
successfully predict the joint effects of
o,p´-DDT, genistein, 4-nonylphenol, and
4-n-octylphenol for mixtures with a fixed
ratio. Rajapakse et al. (2002) and Silva et al.
(2002) extended this approach to the analysis
of mixtures involving 8 and 12 estrogenic
agents, respectively. In both cases, the mixture
responses observed using the yeast estrogen
screen agreed excellently with the effects pre-
dicted using concentration addition. In an
attempt to verify the assumption that concen-
tration addition is an appropriate model for
estrogen mixtures, the authors also compared
the observed mixture effects with additivity
predictions calculated using independent
action. In the study by Payne et al. (2000),
both concepts produced very similar predic-
tions. However, Silva et al. (2002) and
Rajapakse et al. (2002) found that independent
action underestimated the observed mixture
effects by a large margin. 
Examinations of the effects of ternary
mixtures of estrogenic chemicals in an ER-α
gene reporter system based on MCF7 cells
were carried out by Charles et al. (2002a). All
mixtures were examined in a factorial design
involving 64 treatment groups and response
surfaces constructed. Combinations of E2,
17α-ethinylestradiol (EE2), and diethylstilbe-
strol (DES) showed concentration additive
effects when all components were present at
levels that fell within the linear range of their
individual dose–response curves. At higher
concentrations, however, the combined effect
of the three estrogens fell short of expected
additivity, a phenomenon that Charles et al.
(2002a) attributed to saturation effects. In a
second paper, Charles et al. (2002b) investi-
gated ternary combinations of additional
estrogenic chemicals. Although combinations
of benzo[a]pyrene, 1,2-benzanthracene, and
chrysene and of methoxychlor, o,p´-DDT,
and dieldrin showed concentration additivity
over a wide range of mixture ratios, the joint
effects of E2, genistein, and o,p´-DDT were
antagonistic, both in the low and the high
concentration ranges.
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Heneweer et al. (2005) monitored the acti-
vation of ER-α by measuring expression of the
TFF1 gene (trefoil factor 1; coding for the pS2
protein) to study the effects of combinations of
estrogenic ultraviolet filter substances. Binary
mixtures of 2-hydroxy-4-methoxybenzo-
phenone and its metabolite 2,4-dihydroxy-
benzophenone showed concentration additive
effects, as did a combination of these two
chemicals with octyl methoxycinnamate and
3-(4-methylbenzylidene) camphor. In a TEQ
approach, Heneweer et al. (2005) expressed
effect concentrations of the test chemicals in
terms of E2 equivalents. Le Page et al. (2006)
developed a reporter gene assay based on glial
cells (U251-MG) transfected with three
zebrafish ER subtypes and the brain aromatase
promoter linked to luciferase. This system was
used to study a mixture of E2, EE2, estrone,
genistein, and α-zeralenol, with effects well in
agreement with concentration addition.
Cell proliferation. Payne et al. (2001)
found the effects of o,p´-DDT, p,p´-DDT,
p,p´-DDE, and β-hexachlorocyclohexane on
the proliferation of estrogen-dependent
MCF7 cells (E-SCREEN assay) to be concen-
tration additive at two different mixture
ratios, but the observed resposes were equally
well predicted by independent action. Suzuki
et al. (2001) tested binary mixtures of natural
and synthetic estrogenic chemicals, including
E2, estrone, bisphenol A, butyl benzylphtha-
late, endosulfan, methoxychlor, and penta-
chlorophenol, for proliferative effects in
MCF7 cells. Using an effect-multiplication
method to construct contour plots, the
authors observed apparent synergisms with E2
and bisphenol A, whereas the remaining eight
binary combinations gave additive, antagonis-
tic, or weakly synergistic effects. However, the
interpretation of these results is complicated
by the fact that Suzuki et al. (2001) calculated
additivity expectations by multiplication of
unscaled effect measures, a method inconsis-
tent with independent action. Rajapakse et al.
(2004) analyzed mixtures containing E2, EE2,
genistein, bisphenol A, 4-nonylphenol, and
4-tert-octylphenol in the E-SCREEN assay. A
small deviation from concentration additivity
was observed. Interestingly, the omission of
genistein produced an even more pronounced
antagonism. However, a three-component
mixture composed of E2, EE2, and genistein
produced excellent agreement with predicted
concentration additivity, and the same was
observed for a four-component mixture con-
taining E2, EE2, genistein, and bisphenol A.
The presence of 4-nonylphenol and 4-tert-
octylphenol appeared to be associated with
the observed antagonisms (Rajapakse et al.
2004). It is conceivable that differential acti-
vation of metabolizing enzymes (e.g.,
cytochrome P450) or efflux pumps by mix-
ture components can lead to removal of other
constituents, but this hypothesis awaits
experimental confirmation.
Vitellogenin induction in fish. In fish, the
induction of vitellogenin is controlled by
ER-α, and this response can be used to moni-
tor exposure to estrogenic chemicals in juvenile
or male fish. Thorpe et al. (2001) were the first
to exploit this end point to study the effects of
binary mixtures of estrogenic chemicals on
juvenile rainbow trout (Oncorhynchus mykiss).
Over a large range of response levels, a binary
mixture of E2 and 4-nonylphenol followed the
effects predicted by concentration addition,
but a mixture of E2 and the pesticide methoxy-
chlor was less than additive. A binary mixture
of E2 and EE2 also produced concentration
additive effects (Thorpe et al. 2003). In the
largest investigation of this kind so far, Brian
et al. (2005) recorded concentration–response
relationships for E2, EE2, bisphenol A,
4-nonylphenol, and 4-tert-octylphenol for
vitellogenin induction in fathead minnows
(Pimephales promelas) and used this informa-
tion to predict the responses to a mixture of all
five chemicals. This study was truly predictive
because the combination effect predictions had
to rely on single chemical effect data recorded
more than a year before commencement of the
mixture experiment. The observed effects
agreed excellently with the concentration addi-
tion expectation (Brian et al. 2005).
Xie et al. (2005) used the juvenile trout
vitellogenin assay to evaluate mixtures of the
pesticides 2,4-dichlorophenoxyacetic acid
(2,4-D), triclopyr, diquat dibromide, and
plyphosate with two alkyl-phenol ethoxylate–
containing surfactants [R11 (Wilbur-Ellis
Co., San Francisco, CA, USA) and Target
Prospreader Activator (TPA; Target Specialty
Products Fresno, CA, USA)]. Of all pesticides,
only 2,4-D and triclopyr caused enhancements
in vitellogenin levels when given individually,
and R11 and TPA were also effective. Using a
TEQ approach, the additivity expectations
were derived by addition of E2 equivalents.
Binary combinations of 2,4-D with R11 or
with TPA produced essentially concentration-
additive mixture effects (Xie et al. 2005).
However, responses in excess of expected con-
centration additivity were seen with triclopyr
and TPA.
Uterotrophic assays. Charles et al. (2002a)
were the first to confirm the additive effect of
combinations of E2, EE2, and DES using uter-
ine proliferation in immature CD-1 mice as
the end point. Response surfaces constructed
for permutations of each chemical at three dose
levels demonstrated that the combined effects
of all agents were additive. Tinwell and Ashby
(2004) presented a study involving eight estro-
genic chemicals using the uterotrophic assay in
immature rats, but their aim was not to investi-
gate agreement with additivity expectations.
The combined effect of all chemicals was
always larger than the responses observed with
individual components.
Mixtures of Antiandrogens
Androgens are key regulators of male sexual
differentiation during in utero and early post-
natal development. Chemicals that counteract
androgen action at some stage in this period
can lead to malformations of the reproductive
tract. Changes in the anogenital distance,
retained nipples, and alterations in the weight
of sexual organs and accessory glands are fre-
quently studied end points. These effects can
arise through antagonism of androgens at the
steroid receptor level and/or via suppression
of testosterone synthesis in Leydig cells
(Fisher 2004; Gray et al. 2001). Thus, anti-
androgens can be defined narrowly as AR
antagonists, but a broader definition in terms
of counteracting the effects of androgens in a
functional sense (which would include inhibi-
tion of uptake of testosterone precursors, and
of testosterone synthesis steps) has also been
proposed (Gray et al. 2001).
By applying the isobole method, which
is another application of dose addition
(Berenbaum 1981; Loewe and Muischnek
1926), Nellemann et al. (2003) found that
procymidone and vinclozolin, both AR
antagonists, additively inhibited testosterone
binding to the AR. Administration of a 1:1
mixture of both fungizides to castrated, testos-
terone-treated male rats led to dose-additive
alterations in reproductive organ weights,
androgen levels, and AR-dependent gene
expression. Birkhoj et al. (2004) extended the
use of the isobole method to three-component
mixtures of the pesticides deltamethrin,
methiocarb, and prochloraz. An equimolar
mixture of the three pesticides additively sup-
pressed AR activation in vitro. When the
authors gave a combination of these three
chemicals with simazin and tribenuron-
methyl to castrated testosterone-treated rats,
weight changes of the adrenal gland and the
levator ani, as well as alterations in gene
expression of AR-associated genes were
observed. The combination of all five chemi-
cals showed effects that were not found for
the individual pesticides, but whether these
responses were additive could not be assessed.
A mixture of the AR antagonists procymi-
done and vinclozolin was evaluated in the
Hershberger assay, where they acted additively
in reducing ventral prostate and levator ani
weights (Gray et al. 2001). A combination of
procymidone and dibutyl phthalate, an
inhibitor of androgen synthesis, significantly
enhanced the occurrence of hypospadias in
male offspring when given to pregnant rats
during gestational days 14–18. Wolf et al.
(2004) observed that vinclozolin and testos-
terone proprionate, two chemicals with oppos-
ing effects on male sexual differentiation,
Kortenkamp
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antagonized one another during sexual
development of the male rat. A mixture of
butyl benzyl phthalate, an inhibitor of testos-
terone synthesis, and linuron, an AR antago-
nist, decreased testosterone production and
caused alterations of androgen-organized tis-
sues in a dose-additive fashion (Hotchkiss
et al. 2004). Jarfelt et al. (2005) studied
changes in anogenital distance and retained
nipples of male offspring of female rats treated
with di-(2-ethylhexyl) phthalate and di-(2-
ethylhexyl)adipate, but the effects of the mix-
ture were not different from those of each
chemical alone.
Mixtures of Thyroid-Disrupting
Chemicals
Compared with estrogens and antiandrogens,
thyroid-disrupting chemicals are the least
well studied EDs. It is therefore not surpris-
ing that few mixture studies exist using this
kind of agents.
Thyroid-disrupting chemicals can alter
structure and function of the thyroid gland, as
well as the homeostasis of thyroid hormones,
by interfering with associated regulatory
enzymes. Changes in the circulating levels of
thyroid hormones are often the consequence.
A wide variety of chemicals are able to affect
thyroid hormone levels in differing ways.
PCDDs, PCDFs, and PCBs are thought to
suppress circulating thyroid hormone levels by
up-regulating hepatic enzymes that glu-
curonidate thyroxin (T4). Most of the studies
of thyroid-disrupting effects have analyzed the
effects of mixtures without recording responses
induced by individual mixture components;
this complicates assessment of combination
effects in terms of additivity, synergism, or
antagonism. Wade et al. (2002) exposed rats to
a combination of organochlorines and two
heavy metals and analyzed effects on thyroid
histopathology. Using the TCDD (2,3,7,8-
tetrachloro-p-dibenzodioxin) equivalents
method, Desaulniers et al. (2003) found that
the effects of 16 PCBs, PCDDs, and PCDFs
on circulating T4 levels could be predicted well.
Crofton et al. (2005) presented an in-
depth study of a mixture of 18 poly-
halogenated hydrocarbons (2 PCDDs,
4 PCDFs, and 12 coplanar and noncoplanar
PCBs) to investigate the hypothesis that their
joint effect on reducing T4 levels is dose addi-
tive. Young female rats were treated for 4 days
with individual mixture components, and
dose–response relationships with altered T4
levels as the end point were recorded. This
information was used to predict the dose-addi-
tive response to a mixture of all 18 chemicals.
The mixture ratio was chosen to be propor-
tional to the levels of the chemicals reported in
breast milk, fish, and other human food
sources. The dose-additivity model yielded
anticipated effect doses that were higher by a
factor of 2–3 than the observed responses.
This deviation was statistically significant, and
the joint effect of all polyhalogenated pollu-
tants in this model can therefore be classed as
synergistic. Nevertheless, the extent of under-
estimation of observed effects was small.
Summary of Studies with
Similarly Acting EDs
Taken together, there is good evidence that
EDs produce combination effects in a dose-
additive manner. This applies to a wide range
of end points reflecting various hierarchical lev-
els of hormone action in a variety of organisms.
Where deviations from expected additivity
occurred (Charles et al. 2002a, 2002b; Crofton
et al. 2005; Rajapakse et al. 2004; Thorpe et al.
2001), the differences between anticipated and
observed effects were small. Thus, it is safe to
say that for regulatory purposes, the concept of
dose addition is sufficiently accurate for pre-
dicting combination effects of groups of EDs
with similar effects.
The reported deviations are nevertheless
interesting from a conceptual view point.
Toxicokinetic interactions such as differential
activations of metabolizing enzymes in the
mixtures may have played a role, and this
requires further experimental study. For exam-
ple, some estrogenic organochlorines may
induce specific subsets of cytochrome P450
enzymes involved in steroid metabolism, thus
leading to increased removal of steroidal estro-
gens from the mixture, with a certain loss of
activity. This may explain the slightly lower-
than-expected combination effects observed in
the E-SCREEN assay by Rajapakse et al.
(2004). Similar considerations may apply to
the mixture of thyroid-disrupting chemicals
analyzed by Crofton et al. (2005), where many
diverse mechanisms are at play leading to
reductions in circulating T4 levels.
Combination Effects between
Different Classes of EDs
Comparatively little work has been performed
with mixtures of different classes of EDs, such
as estrogenic agents combined with anti-
estrogenic chemicals, or EDs combined with
other toxicants. In terms of design and data
assessment, this type of study differs from
those discussed so far, because not all compo-
nents present in the mixture may induce the
effect chosen for analysis. In these cases, a
“modulatory” influence of toxicants on the
effects of other chemicals is studied. It is
important to realize that the magnitude of
such effect modulations cannot be predicted
by adopting additivity concepts such as con-
centration addition or independent action.
Perhaps the best-known example of effect
modulation is the inhibitory effect of AhR ago-
nists, such as PCDDs and co-planar PCBs, on
the action of estrogenic chemicals. Although
not estrogenic themselves, AhR agonists have
been reported to suppress some E2-induced
responses, not by antagonizing hormone bind-
ing to the ER but by down-regulation of ER
expression, induction of steroid-metabolizing
enzyme systems such as CYP 1A1 and 1A2,
and inhibiting various growth factors and cell
cycle regulators (Chen et al. 2001, Reen et al.
2002, Safe 1998). There is a rich literature
about the molecular biology underlying the
interactions between dioxins and estrogens
(Sone and Yonemoto 2002).
Somewhat misleadingly, the action of AhR
agonists has been called antiestrogenic, when it
is perhaps more appropriate to view them as
disruptors of estrogen signaling. The dioxin
TCDD has been reported to inhibit the estro-
gen-induced proliferation of uterine tissue in
immature mice (Gallo et al. 1986) and to lead
to diminuitions of ER levels in the liver and
the uterus. Modulations of ER levels by
TCDD were also described in rats (Astroff and
Safe 1988; Romkes and Safe 1988; Romkes
et al. 1987). Although down-regulation of ER
expression by AhR agonists in cell models is
not controversial, difficulties with reproducing
the effects in rodents have led to questions
about the relevance of antiestrogenic effects of
AhR in vivo. White et al. (1995) examined the
impact of TCDD on the keratinization of the
vaginal epithelium and uterine proliferation in
Sprague-Dawley rats induced by E2, but they
failed to observe any inhibitory effects of
TCDD. Uterine ER and progesterone receptor
levels were also not affected, although toxicity
typical of TCDD (reductions in thymus
weight, induction of hepatic CYP 1A1)
occurred. Similarly, Desaulniers et al. (2003)
did not observe an influence of a mixture of
16 AhR agonists (various PCDDs, PCDFs,
and PCBs) on uterine growth stimulated by
EE2 in prepubertal female Sprague-Dawley
rats. Although the reasons for these contra-
dictory findings remain to be fully elucidated,
Desaulniers et al. (2003) pointed to reports by
Petroff et al. (2001) and Sarkar et al. (2000) of
enhancements of TCDD-induced AhR
expression and CYP 1A1 induction in the
presence of E2. This could explain the lack of
antiestrogencity of AhR agonists in their
study. White et al. (1995) even questioned the
validity of ascribing a specific antiestrogenic
property to TCDD in the rat. They pointed
out that inhibitory actions of TCDD on E2-
induced effects reported by Safe and col-
leagues (Astroff and Safe 1988; Romkes and
Safe 1988; Romkes et al. 1987) occurred at
TCDD doses similar to the median lethal dose
(LD50) for the Sprague-Dawley and Long-
Evan strains. Because TCDD induces a well-
known wasting syndrome, it is conceivable
that the antiestrogenicity of TCDD is in fact
the result of such systemic toxicity, rather than
due to specific effects opposing the action of
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the hormone. Thus, more work is required to
evaluate whether disruption of estrogen signal-
ing by AhR agonists occurs at realistic doses,
and whether doses shown to interfere with
estrogen-mediated biochemical effects, such as
changes in gene expression, also lead to sup-
pression of estrogen action with more apical
end points, such as cell proliferation.
Epidermal growth factor (EGF) and
insulin-like growth factor (IGF) are able to
enhance estrogen signaling by inducing ER
phosphorylation and other signaling events
(Aronica and Katzenellenbogen 1993; Ignar-
Trowbridge et al. 1996). These observations
prompted Charles et al. (2002a) to study the
impact of EGF and IGF on E2-induced activa-
tion of ER in an MCF7 cell–based reporter
gene system. Several combinations of all three
agents were investigated and response surfaces
recorded. Although EGF and IGF, on their
own, did not promote gene transcription in
this model, there were enhancements of the
effects of E2, mostly caused by EGF. These
results indicate that the presence of growth fac-
tors may sensitize ER-competent cells to the
action of the hormone, with significant conse-
quences in terms of lowered effect thresholds.
It remains to be seen whether similar effects
also occur with estrogen-like environmental
pollutants. Without a doubt, the potential for
greater-than-additive interactions through
interference with interacting signaling path-
ways deserves further attention and should be
investigated systematically.
Low-Dose Mixture Effects
In the context of discussions about EDs, vari-
ous often-conflicting definitions of the term
“low dose” have been used. “Low dose” is vari-
ously taken to mean “doses lower than used
normally in toxicity testing”; “doses that
approach, or are equal to, those encountered
by humans”; or “doses associated with low
effects” (National Toxicology Program 2001;
vom Saal and Hughes 2005). Not all of these
definitions have proven useful in guiding
experimental work aimed at investigating
whether mixtures of EDs provoke effects at
low doses. Many of the chemicals suspected of
being EDs have not yet been subjected to toxi-
city testing and consequently, “doses lower
than used normally in toxicity testing” are dif-
ficult to define. Similarly, the resolving power
of most in vivo and many in vitro assays is
insufficient to demonstrate effects of combina-
tions of agents at doses approaching human
exposure levels. For these reasons, low-dose lev-
els in mixture studies were selected by adhering
to the last of the above definitions [i.e., “low
dose” in the sense of doses that produce low
effects, usually around or below no observed
effect levels (NOELs)]. Although such doses
may be relatively large compared to human
exposure levels, the relevant experimental
studies provided valuable insights into the
potential of EDs to act together at low doses. 
The concept of dose addition implies that
every effective agent in the mixture, at any
dose, contributes more or less to the overall
combination effect. Crucially, this also holds
true when the individual doses are without
effect. Thus, combination effects should also
result from agents present at or even below
effect thresholds, provided sufficiently large
numbers of components sum up to a suffi-
ciently high total effect dose. It may be helpful
to illustrate these implications of dose addition
by adopting a thought experiment first pre-
sented by Berenbaum (1981). Let us consider
a large number of chemicals that by chance all
exhibit the same sigmoidal dose–response
curve. At small doses, the effect produced by
one single component is too small to be distin-
guishable from untreated controls. However,
the response expected from combining
10 chemicals at this same low dose is equiva-
lent to the effect of a 10-fold higher dose,
because all components are assumed to exhibit
the same dose–response relationship. The pro-
cedure can be repeated with infinitesimally
small doses below effect thresholds; as long as
there are sufficiently high numbers of chemi-
cals present simultaneously, combination
effects should result.
The good agreement of ED mixture effects
with dose addition makes it an attractive
proposition to review whether these theory
expectations are in line with experimental
observation. Silva et al. (2002) assessed combi-
nations of eight xenoestrogens in the yeast
estrogen screen at concentrations of 50% of
their no observed effect concentrations
(NOECs) and observed responses of up to
40% of a maximal estrogenic effect. Using the
same assay, Rajapakse et al. (2002) set out to
investigate whether low levels of weak xeno-
estrogens would be able to modulate the
effects of E2. A combination of 11 xeno-
estrogens, all present at levels around their
individual NOECs, led to a doubling of the
effects of E2. Tinwell and Ashby (2004) com-
bined 8 estrogenic chemicals at doses that gave
no significant uterotrophic responses when
tested on their own. When administered
together, quite strong uterotrophic effects
were observed. The mixture experiments with
5 estrogenic chemicals in fathead minnows
(Pimephales promelas) presented by Brian et al.
(2005) also demonstrated combination effects
at concentrations that individually did not
induce vitellogenin synthesis. The 18 thyroid-
disrupting chemicals chosen by Crofton et al.
(2005) to analyze changes in T4 levels were all
present at doses equivalent to, or even below,
their individual NOELs.
These examples clearly demonstrate that
combinations of EDs with similar effects are
able to act together at doses that when used
alone do not lead to observable effects. The
experimental evidence is in line with the
assumptions of dose addition. Combination
effects may result from cumulative exposure to
EDs if they are present in sufficiently large
numbers at levels equivalent to fractions of
their individual NOELs. However, whether
mixture effects will indeed occur is difficult to
anticipate without comprehensive information
about the levels and the identity of EDs in the
environment and in human tissues. This is
where one of the major challenges for mixture
assessment currently lies: Our information
about the occurrence of EDs in humans and
the environment is patchy. Considerable
efforts in mixture exposure assessment need to
be made to fill these gaps; exposure assess-
ment, and not hazard assessment, currently
represents the “bottleneck” for making further
progress in this important area.
Implications for Regulatory
Strategies
It is evident that the traditional chemical-by-
chemical approach to risk assessment is inade-
quate when dealing with EDs (and chemicals
with other toxic profiles). The biological real-
ity of combination effects from exposure to
multiple agents at low doses highlights the
potential for underestimating risks when mix-
ture effects are not taken into account. This
underlines the need to modify current risk
assessment practice if humans and the envi-
ronment are to be protected adequately from
multiple exposures to EDs. As a first step in
the direction of implementing better risk
assessment, the idea of grouping EDs accord-
ing to suitable similarity criteria suggests itself,
as is already common practice with the group-
wise assessment of AhR agonists such as
PCDDs, PCDFs, and PCBs in the TEF/TEQ
approach. For example, in a recent opinion
paper, the European Scientific Committee
on Toxicology, Ecotoxicology and the
Environment (Commission of the European
Communities 2004) pointed out that 
For compounds with an identical mode of action,
such as oestrogenic hormones and xeno-estrogens
that act through an oestrogen receptor, the perfor-
mance of individual risk assessments is problematic.
For example, the effects of natural and synthetic
oestrogens may be additive, especially since these
chemicals co-occur in the aquatic environment.
Criteria for defining similar modes of
action. The challenge lies in defining what
“identical modes of action” could mean for
EDs, and how this could be translated into
workable criteria for grouping EDs according
to similar modes of action. The issue is linked
to the general problem of defining “similar
action” for purposes of mixture assessments,
but unfortunately there are currently no unam-
biguous criteria for what should constitute
similar action (Mileson et al. 1998). Often, the
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induction of the same phenomenological effect
is deemed sufficient for accepting similar
action. At the other extreme of the spectrum of
opinions, an identical molecular mechanism
involving the same active intermediate is
required to fulfill the similarity assumption. A
middle position is occupied by the view that
interactions with the same site, tissue, or target
organ should qualify for similarity.
One suggestion would be to group EDs
according to the steroid receptors with which
they interact. Thus, all estrogens, for example,
could be regulated together. However, in tak-
ing this approach, the criteria chosen for
grouping should be considered carefully. Too
narrow a focus on molecular mechanisms
might lead to problems and prove unwork-
able. The issue can be illustrated using anti-
androgens as an example. With a narrow focus
on identical modes of action, all AR antago-
nists could be considered, but this would leave
out agents that are able to disrupt male sexual
development by interfering with steroid syn-
thesis, such as certain phthalates. Thus, appli-
cation of a phenomenological similarity
criterion (all agents that disrupt male sexual
development by inducing changes in anogeni-
tal distance) would serve the group of anti-
androgens better.
A similar case can be made for estrogenic
or estrogen-like chemicals. Grouping these
chemicals according to their ability to activate
the ER-α would leave out ER-β agonists,
although there is considerable overlap.
However, the molecular mode of action is dif-
ferent in both cases. Furthermore, the phe-
nomenon of ligand-independent activation of
steroid receptors (e.g., by phosphorylations via
mitogen-activated phosphokinase cascades and
activation of receptor tyrosine kinases) has
become well-established (Picard 2003), and
steroid hormones themselves are able to induce
these signaling events. If a similarity criterion
for estrogens is defined in a strict molecular
way, for example, solely in terms of binding to
the E2-binding pocket with subsequent activa-
tion of the helix 12 “mousetrap” mechanism,
then a wealth of additional mechanisms of ER
activation would be left disregarded, although
these processes may well contribute to joint
effects in living organisms. In this context, the
question of sensitization to the effects of xeno-
estrogens by growth factors is particularly rele-
vant. Thus, for estrogens, it would be more
appropriate to adopt a phenomenological simi-
larity criterion and to use the classical definition
of estrogens (induction of proliferation of tis-
sues of the female reproductive tract) for pur-
poses of grouping in terms of similar action.
In the case of thyroid-disrupting chemicals,
many different mechanisms are at play that all
may lead to reductions in thyroid hormone
levels. These include, but are not limited to,
inhibition of uptake of iodide into the thyroid
gland, disruption of thyroid hormone synthe-
sis by inhibition of thyroid peroxidase, and
alterations of the levels of circulating thyroid
hormones by increased activity of uridine
diphosphoglucuronosyl transferases. These
enzymes are inducible by nuclear receptors
such as PXR and CAR, which in turn respond
to a wide variety of chemicals with differing
structural features. Thus, it would be impossi-
ble to define thyroid-disrupting chemicals in
terms of strict molecular similarity, and only a
phenomenological approach has any prospect
of producing workable grouping criteria.
A particular problem arises with chemicals
that have been shown to interfere with signal-
ing from several steroid receptors. An example
is the ubiquitous environmental pollutant
p,p´-DDE, which is a weak ER agonist and
also an AR antagonist. It appears that many
AR antagonists turn out to be ER agonists,
and vice versa (Kojima et al. 2004).
The TEF approach for EDs? The usefulness
of the TEF/TEQ approach for hazard and risk
assessment of ED mixtures has been reviewed
by Safe (1998). The TEF approach is an appli-
cation of the concept of dose addition. Given
the good agreement of ED mixture effects with
dose addition and considering that the TEF
approach is relatively straightforward to use, it
would appear uniquely suited for the joint
assessment of specific groups of EDs. For many
PCDD/PCDF mixtures, calculated TEQs
agree well with experimentally determined
TEQs (Desaulniers et al. 2003; Hamm et al.
2003; Safe 1998; van den Berg et al. 1998).
However, as Safe (1998) pointed out, the
main problem in adopting the TEF approach
for ED mixtures lies in the biological reality of
interactions between different response path-
ways and signaling webs activated by diverse
agents. The available evidence in the literature
(Charles et al. 2002a) demonstrates that such
interactions may lead to enhancements or sup-
pressions of effects not captured by the addi-
tivity assumption of the TEF concept. This
may become particularly relevant when non-
linear toxicokinetic factors are at work that
alter TEFs derived from in vivo studies at
higher doses. Interactions of this kind may
also compromise the usefulness of TEFs
derived from in vitro assays when comparisons
to the in vivo situation are made.
The TEF concept relies on a standard or
reference compound that is used to define
TEFs for individual chemicals in the same class
of compounds. In the case of PCDDs and
PCDFs, this is TCDD; for estrogenic chemi-
cals, the endogenous hormone E2 suggests
itself as a reference for defining TEFs.
However, for lack of an endogenous agent, it is
not straightforward to define a standard anti-
androgen, although in principle this problem
can be overcome by agreeing on an arbitrary
choice of a particular chemical.
More difficult to deal with are violations of
another assumption implicit in the use of the
TEF approach: the requirement that the dose–
response curves for all congeners of a group of
chemicals should be parallel. If this assumption
is not fulfilled, the TEF will vary depending on
the effect levels chosen for deriving their
numerical values. Parallel dose–response curves
have often been observed with EDs but are by
no means the general rule, and this militates
against the general applicability of the TEF
approach for ED mixtures.
Suggestions for a temporary solution. Safe’s
(1998) main argument against the generalized
use of the TEF approach for ED mixtures (i.e.,
the richness and variety of activation of inter-
acting signaling webs with their potential of
nonadditive joint effects) carries a lot of force.
There can be no doubt that future research
should further characterize these interactions
and their potential to modulate the action of
hormone-like agents. On the other hand, the
overwhelming evidence showing that groups
of estrogenic, antiandrogenic, and thyroid-
disrupting chemicals act together in an addi-
tive fashion cannot be ignored. The progress
that has been made in the last 10 years in
assessing ED mixtures severely compromises
the credibility of continued use of the chemi-
cal-by-chemical approach to risk assessment. It
is likely that future research into ED signaling
cross-talk will uncover better criteria for deal-
ing with these chemicals in a more holistic
way, but until then, lack of this knowledge
should not prevent regulators from making the
best use of available empirical evidence.
Therefore, I suggest that EDs be temporar-
ily grouped and that these groups be subjected
to common hazard and risk assessment. Great
care should be taken not to apply inappropri-
ately restrictive criteria in carrying out these
classifications. EDs should be arranged accord-
ing to their ability to provoke similar effects,
rather than according to similar mechanisms of
action. Given that the expectation of parallel
dose–response curves is unrealistic, use of the
TEF concept should be avoided. Instead, dose
addition should be preferred for calculating
quantitative additivity expectations, if neces-
sary, even in the absence of empirical data
about mixture effects.
Research Recommendations
As I have demonstrated in this article, compara-
tively little information exists concerning the
ways in which EDs belonging to different
classes may interact to produce combined
effects. As a result, research efforts should be
focused to pursue this area of study. For exam-
ple, antiandrogens, including AR antagonists
and inhibitors of steroid synthesis, should be
combined with estrogenic agents that also pos-
sess antiandrogenic properties to allow the
study of possible impacts on disruption of male
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sexual development in vivo. PCDDs, PCDFs,
and PCBs are well-known disruptors of male
sexual development, but very little is known
about how they act together with antiandrogens
and estrogens, and it is urgent to fill this gap.
Another knowledge gap that needs to be
bridged concerns possible interactions between
growth factors such as EGF and IGF with nat-
ural steroid hormones and xenoestrogens. A
better understanding of the joint effects of
these agents is required to evaluate environ-
mental factors that are important in the forma-
tion of breast cancer. There is already evidence
demonstrating a potential for synergism
between steroid hormones and growth factors
(Charles et al. 2002a), but studies building on
this knowledge are required to evaluate poten-
tial interactions between growth factors and
xenoestrogens. This area of investigation could
be enhanced further by analyzing the role of
signaling cross talk between natural dietary
components that activate retinoid receptors
and ER pathways.
Of particular interest are combinations of
chemicals in which not all components pro-
duce the effect to be analyzed, but where some
may significantly modulate the effects of oth-
ers, without themselves being effective. By
their very nature, the impact of such effect
modulators will not be predictable quantita-
tively by employing the usual additivity expec-
tations in mixture toxicology. However, it is
necessary to explore whether the direction of
such effect modulations can be anticipated in
qualitative terms by analyzing interactions at
the level of metabolism and transport. The
approach taken could use existing databases
for the visualization of complex gene and sig-
naling networks as a mining and analytical
tool for hypothesis generation (Ekins et al.
2006). Signaling nodes and interaction points
identified in this way could then be targeted
experimentally by gene expression profiling
and proteomics techniques. This will also
allow assessments of the usefulness of such
data mining and experimental approaches for
the grouping of EDs into classes with similar
effect profiles.
Exposure assessment has revealed itself as
another major limiting factor that is currently
hampering progress with ED mixtures.
Information exists about the concentrations of
many individual chemicals in human tissues
and in the environment, but data concerning
the levels of multiple chemicals in the same
samples are scarce. Put simply, we need to
know whether women in agricultural areas in,
say, Spain, who exhibit elevated levels of cer-
tain pesticides in their tissues also show high
levels of phthalates from copious use of per-
sonal care products and cosmetics. To date,
this information is not available, and it will
require dedicated, targeted mixture exposure
assessment strategies to fill this gap. 
Perhaps the greatest challenge will be to
develop ways in which concepts for mixture
effect assessment can be used productively in
epidemiology. Epidemiology has traditionally
focused on defining the impact of single
chemicals on disease outcomes, and only very
few examples exist where the role of combina-
tions of chemicals could be evaluated. As an
example relevant to endocrine disruption, the
shortcomings of traditional single-chemical
epidemiology on elucidating causes for
breast cancer have been previously discussed
(Kortenkamp 2006). In order to develop
viable approaches to solving this problem, the
concerted efforts of mixture toxicology experts,
exposure assessors, and epidemiologists will
be required.
Conclusion
In the last 10 years, considerable progress has
been made in assessing the effects of multi-
component mixtures of EDs. Work has
focused on mixtures with components belong-
ing to certain classes of EDs, such as estro-
genic, antiandrogenic, and thyroid-disrupting
chemicals; these studies have demonstrated the
usefulness of the concept of dose addition in
anticipating combination effects. Good evi-
dence is available to show that joint effects
occur even when all mixture components are
present at levels below doses that cause observ-
able effects. In view of this evidence, the tradi-
tional chemical-by-chemical approach to risk
assessment is hard to justify, and the ground is
prepared to seriously consider group-wise regu-
lation of EDs. In spite of serious shortcomings
in our understanding of signaling cross talk
between categories of EDs, we should group
these chemicals according to their ability to
induce similar effects (as opposed to similar
mechanisms) until better mechanistic informa-
tion in forthcoming. This modus operandi is
only viable with a concurrent, targeted research
program aimed at improving our understand-
ing of ED mixtures. Future research should
particularly focus on combinations of EDs that
belong to different categories.
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